Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Bendamustine in Relapsed/Refractory Follicular Lymphoma
NCT01127841Phase 2Unknown
- Sponsor
- GOTEL
- Start
- Jul 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab, bendamustine in follicular lymphoma (FL), sponsored by GOTEL. Status: unknown.
02
Drugs
rituximabbendamustine
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01127841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01127841.